Home / Institutions / Rubric Capital Management LP
13F holdings

Rubric Capital Management LP portfolio

Managed by . 82 reported positions worth $8.2B as of 2026-03-31, filed with the SEC on 2026-05-15. Parsed from the filing itself, not a reseller.

$8.2B
Book value
82
Positions
52%
Top 10 weight
+16
New this quarter
-10
Exited
134 days
Age today
How old this actually is

Every position on this page is a snapshot of 2026-03-31. It was already 45 days old on 2026-05-15, the day it first became public. Today it is 134 days old.

That lag is the law, not a service level — Rule 13f-1 gives managers 45 days after quarter end to file, and no product can shorten it. A fund can have sold every share below before you read this sentence. Treat it as a record of what happened, never as a position you can follow.

What changed

Positions opened and closed

Against its 2025-12-31 filing. This is the part worth reading — the holdings table below is mostly years old.

New positions (16)
TickerIssuerValueShares% of book
ZMZOOM COMMUNICATIONS INC$80.5M1,001,0060.99%
AMCRAMCOR PLC$50.5M1,269,3960.62%
PTGXPROTAGONIST THERAPEUTICS INC$45.1M427,9980.55%
DRVNDRIVEN BRANDS HLDGS INC$37.8M3,000,0000.46%
CALAVO GROWERS INCCALAVO GROWERS INC$36.5M1,416,6620.45%
VISNVISTANCE NETWORKS INC$36.4M2,000,0000.45%
BMRNBIOMARIN PHARMACEUTICAL INC$24.9M440,5600.30%
AVOMISSION PRODUCE INC$23.8M1,726,4470.29%
VGVENTURE GLOBAL INC$23.6M1,500,0000.29%
INDVINDIVIOR PHARMACEUTICALS INC$20.2M662,5150.25%
ADMAADMA BIOLOGICS INC$16.3M1,809,4080.20%
DNOWDNOW INC$15.1M1,267,5270.18%
ARDXARDELYX INC$11.1M1,860,8960.14%
AEROGRUPO AEROMEXICO SAB DE CV$6.5M467,1290.08%
EPRXEUPRAXIA PHARMACEUTICALS INC$5.0M691,1700.06%
PFSIPENNYMAC FINL SVCS INC NEW$4.8M54,7270.06%
Closed out (10)
TickerIssuerWas worthShares% of book
FLRFLUOR CORP NEW$164.2M4,143,8080.00%
EOSEEOS ENERGY ENTERPRISES INC$74.5M6,500,0000.00%
ADMARCHER DANIELS MIDLAND CO$63.3M1,101,5830.00%
BGBUNGE GLOBAL SA$60.3M676,5100.00%
GPKGRAPHIC PACKAGING HLDG CO$30.1M2,000,0000.00%
NFENEW FORTRESS ENERGY INC$27.0M23,701,3990.00%
DARDARLING INGREDIENTS INC$24.5M680,8270.00%
INDVINDIVIOR PLC$17.9M498,5270.00%
SWSMURFIT WESTROCK PLC$15.5M400,0000.00%
STUBSTUBHUB HLDGS INC$10.6M784,8540.00%
Added to (25)
TickerIssuerValueShares% of bookShares Δ
VTRSVIATRIS INC$452.6M33,500,0005.54%+31%
BGCBGC GROUP INC$227.9M23,300,0002.79%+11%
CEGCONSTELLATION ENERGY CORP$199.7M715,0002.45%+7%
MCYMERCURY GENL CORP NEW$189.9M2,154,5042.33%+5%
KNSAKINIKSA PHARMACEUTICALS INTL$180.6M3,750,0002.21%+13%
ZYMEZYMEWORKS INC$175.3M7,000,0002.15%+22%
AKAMAKAMAI TECHNOLOGIES INC$149.3M1,300,0001.83%+8%
LBTYALIBERTY GLOBAL LTD$142.1M11,752,8551.74%+17%
LILAKLIBERTY LATIN AMERICA LTD$135.8M15,395,4301.66%+44%
CMPRCIMPRESS PLC$118.9M1,629,4191.46%+7%
LBTYKLIBERTY GLOBAL LTD$108.6M9,259,3611.33%+51%
EPCEDGEWELL PERSONAL CARE CO$85.4M4,000,0001.05%+297%
GILGILDAN ACTIVEWEAR INC$77.7M1,395,7900.95%+444%
SDGRSCHRODINGER INC$68.2M6,000,0000.84%+44%
SPRYARS PHARMACEUTICALS INC$64.2M8,000,0000.79%+29%
Trimmed (14)
TickerIssuerValueShares% of bookShares Δ
PRLBPROTO LABS INC$27.7M486,4000.34%-57%
MNKDMANNKIND CORP$8.9M3,620,4130.11%-52%
COMPCOMPASS INC$27.4M3,746,8480.34%-46%
ROIVROIVANT SCIENCES LTD$138.5M5,000,0001.70%-44%
FTAIFTAI AVIATION LTD$631.2M2,576,1867.73%-30%
TEVATEVA PHARMACEUTICAL INDS LTD$459.3M15,250,0005.63%-29%
VSTVISTRA CORP$225.5M1,500,0002.76%-25%
PRMBPRIMO BRANDS CORPORATION$52.4M2,782,4040.64%-23%
ANDEANDERSONS INC$61.4M855,8190.75%-15%
COLLCOLLEGIUM PHARMACEUTICAL INC$42.3M1,279,6110.52%-14%
ECVTECOVYST INC$117.5M9,136,0671.44%-13%
QDELQUIDELORTHO CORP$54.3M3,306,2810.67%-12%
AMRXAMNEAL PHARMACEUTICALS INC$137.2M11,037,5891.68%-11%
TRVITREVI THERAPEUTICS INC$44.3M3,712,3730.54%-1%
The book

All reported holdings

TickerIssuerValueShares% of bookShares Δ
TLNTALEN ENERGY CORP$1.1B3,602,17114.09%
FTAIFTAI AVIATION LTD$631.2M2,576,1867.73%
GLNGGOLAR LNG LTD$496.7M9,178,9786.08%
TEVATEVA PHARMACEUTICAL INDS LTD$459.3M15,250,0005.63%
VTRSVIATRIS INC$452.6M33,500,0005.54%
TACTRANSALTA CORP$232.9M17,781,3252.85%
BGCBGC GROUP INC$227.9M23,300,0002.79%
VSTVISTRA CORP$225.5M1,500,0002.76%
CEGCONSTELLATION ENERGY CORP$199.7M715,0002.45%
ARQTARCUTIS BIOTHERAPEUTICS INC$194.9M8,271,5772.39%
MCYMERCURY GENL CORP NEW$189.9M2,154,5042.33%
KNSAKINIKSA PHARMACEUTICALS INTL$180.6M3,750,0002.21%
ZYMEZYMEWORKS INC$175.3M7,000,0002.15%
AKAMAKAMAI TECHNOLOGIES INC$149.3M1,300,0001.83%
LBTYALIBERTY GLOBAL LTD$142.1M11,752,8551.74%
ROIVROIVANT SCIENCES LTD$138.5M5,000,0001.70%
AMRXAMNEAL PHARMACEUTICALS INC$137.2M11,037,5891.68%
LILAKLIBERTY LATIN AMERICA LTD$135.8M15,395,4301.66%
DKDELEK US HLDGS INC NEW$121.1M2,687,4491.48%
CMPRCIMPRESS PLC$118.9M1,629,4191.46%
ECVTECOVYST INC$117.5M9,136,0671.44%
LBTYKLIBERTY GLOBAL LTD$108.6M9,259,3611.33%
ADEAADEIA INC$102.9M4,284,2051.26%
EPCEDGEWELL PERSONAL CARE CO$85.4M4,000,0001.05%
ZMZOOM COMMUNICATIONS INC$80.5M1,001,0060.99%
TDSTELEPHONE & DATA SYS INC$77.9M1,850,0000.95%
GILGILDAN ACTIVEWEAR INC$77.7M1,395,7900.95%
IARTINTEGRA LIFESCIENCES HLDGS C$73.0M7,753,9340.89%
SDGRSCHRODINGER INC$68.2M6,000,0000.84%
SPRYARS PHARMACEUTICALS INC$64.2M8,000,0000.79%
GEOGEO GROUP INC$62.9M3,743,1800.77%
SSYSSTRATASYS LTD$62.5M8,000,0000.77%
ANDEANDERSONS INC$61.4M855,8190.75%
MGTXMEIRAGTX HLDGS PLC$60.6M7,000,0000.74%
ENOVENOVIS CORPORATION$55.8M2,453,2650.68%
OPKOPKO HEALTH INC$54.5M47,791,2430.67%
QDELQUIDELORTHO CORP$54.3M3,306,2810.67%
PRMBPRIMO BRANDS CORPORATION$52.4M2,782,4040.64%
NWLNEWELL BRANDS INC$52.3M15,257,4310.64%
AMCRAMCOR PLC$50.5M1,269,3960.62%
RNWRENEW ENERGY GLOBAL PLC$50.4M11,000,0000.62%
PRTAPROTHENA CORP PLC$48.6M5,000,0000.60%
PTGXPROTAGONIST THERAPEUTICS INC$45.1M427,9980.55%
TRVITREVI THERAPEUTICS INC$44.3M3,712,3730.54%
OFIXORTHOFIX MED INC$42.7M3,721,7150.52%
COLLCOLLEGIUM PHARMACEUTICAL INC$42.3M1,279,6110.52%
CXWCORECIVIC INC$38.9M2,059,2160.48%
NRIXNURIX THERAPEUTICS INC$38.3M2,473,8850.47%
DRVNDRIVEN BRANDS HLDGS INC$37.8M3,000,0000.46%
CALAVO GROWERS INCCALAVO GROWERS INC$36.5M1,416,6620.45%
CRICARTERS INC$36.4M1,018,8530.45%
VISNVISTANCE NETWORKS INC$36.4M2,000,0000.45%
MATVMATIV HOLDINGS INC$34.6M3,982,4420.42%
LILALIBERTY LATIN AMERICA LTD$32.4M3,750,0000.40%
TSATTELESAT CORP$30.5M843,7810.37%
ABUSARBUTUS BIOPHARMA CORP$29.8M6,626,3890.37%
PRLBPROTO LABS INC$27.7M486,4000.34%
COMPCOMPASS INC$27.4M3,746,8480.34%
BMRNBIOMARIN PHARMACEUTICAL INC$24.9M440,5600.30%
HRTXHERON THERAPEUTICS INC$24.0M30,046,8280.29%
AVOMISSION PRODUCE INC$23.8M1,726,4470.29%
VGVENTURE GLOBAL INC$23.6M1,500,0000.29%
XPERXPERI INC$23.2M4,143,7440.28%
THTARGET HOSPITALITY CORP$20.3M2,189,4560.25%
INDVINDIVIOR PHARMACEUTICALS INC$20.2M662,5150.25%
ACHCACADIA HEALTHCARE COMPANY IN$19.9M850,0000.24%
ADMAADMA BIOLOGICS INC$16.3M1,809,4080.20%
DNOWDNOW INC$15.1M1,267,5270.18%
SEGSEAPORT ENTMT GROUP INC$12.2M568,5300.15%
CPRICAPRI HOLDINGS LIMITED$11.9M675,0000.15%
ARDXARDELYX INC$11.1M1,860,8960.14%
EMBCEMBECTA CORP$9.2M1,037,4160.11%
MNKDMANNKIND CORP$8.9M3,620,4130.11%
AEROGRUPO AEROMEXICO SAB DE CV$6.5M467,1290.08%
HELEHELEN OF TROY LTD$5.3M366,2260.06%
MREOMEREO BIOPHARMA GROUP PLC$5.1M15,307,3470.06%
EPRXEUPRAXIA PHARMACEUTICALS INC$5.0M691,1700.06%
PFSIPENNYMAC FINL SVCS INC NEW$4.8M54,7270.06%
EDSAEDESA BIOTECH INC$3.6M687,5000.04%
TXMDTHERAPEUTICSMD INC$2.4M1,192,1910.03%
OPK 3.75 01/15/29OPKO HEALTH INC$1.5M1,250,0000.02%
MYPSPLAYSTUDIOS INC$1.3M2,697,3840.02%

This manager also disclosed 1 options positions with a combined notional of $1.3B. Notional is not ownership, so it is excluded from the book value above rather than folded in to make the fund look bigger.

Rows are aggregated by CUSIP — a manager files the same security multiple times when different internal desks hold it. Tickers link to our own backtest of that asset where we cover it.

Read the original

This page was built from one document: the 2026-03-31 Form 13F info table filed by Rubric Capital Management LP (CIK 1687509, accession 0001104659-26-062466). Every other 13F site is reading the same file.

If anything here disagrees with it, the filing wins — and we would want to know. All 13F filings by this manager

What a 13F cannot show you

A 13F is a long-only equity snapshot, and the holes in it are structural. Anyone selling you this data as "what the smart money is doing" is selling you one leg of a position:

  • No short positions. None, ever. A fund shown here as bullish may be net short the same name through a book you cannot see.
  • No cash, bonds, FX, commodities or non-US listings. A macro fund's entire thesis can be invisible.
  • No intra-quarter round trips. Bought and sold inside the same quarter means it never appears at all.
  • Options are notional, not ownership. We keep puts and calls in a separate bucket rather than adding their notional into a fund's book size, which is how a $2B fund gets reported as a $20B one.
  • Confidential treatment. Managers can ask the SEC to withhold a position while they build it. Those holdings are legally absent from the filing, so a "new" position may be months old.

Tested and published by IndicatorEdge · backtest grid generated 2026-06-25 · base rates recomputed 2026-07-31 · how we test

Free · no spam

Get the weekly edge report

The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.